Our Press Releases
Article Category
Amyotrophic lateral sclerosis (ALS)
Review over Amyotrophic Lateral Sclerosis (ALS) and the First FDA-Approved Drug for Treatment of
Dapagliflozin in Patients with Type 2 Diabetes
Benefits of Dapagliflozin When in Patients with Type 2 Diabetes Abstracts Dapagliflozin reduces the
Breast Cancer Awareness Month
Breast Cancer Awareness October is Breast Cancer Awareness Month, an annually campaign to raise
Comprehending Heart Failure and Its Therapeutic Approaches
Comprehending Heart Failure and Its Therapeutic Approaches Introduction to Heart Failure Heart failure
Understanding Type 2 Diabetes and Medications for Management
Type 2 diabetes is a prevalent chronic condition, that affects millions of people
Molnupiravir
Molnupiravir may be effective against the omicron sub-variant BA.5 According to a study
Soft Tissue Sarcoma
Tyrosine kinase inhibitors in Soft Tissue Sarcomas treatment Sarcomas are a group of
Tofacitinib the first FDA approved JAK inhibitor
An overview of Tofacitinib, the first FDA approved JAK inhibitor, and its Indications Introduction Tofacitinib
increase Risk of Developing Diabetes
COVID-19 infection even mild ones may increase Risk of Developing Diabetes A recent